CGEN - コンピュジェン (Compugen Ltd.)

CGENのニュース

   A stock that deserves closer examination: Compugen Ltd. (CGEN)  2022/10/31 15:24:00 US Post News
A share of Compugen Ltd. (NASDAQ:CGEN) closed at $0.88 per share on Friday, up from $0.81 day before. While Compugen Ltd. has overperformed by 7.76%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CGEN fell by -86.52%, with highs and lows ranging from $7.48 to $0.51, […]
   Compugen to Release Third Quarter 2022 Results on Monday, November 14, 2022  2022/10/31 11:00:00 PR Newswire
HOLON, Israel, Oct. 31, 2022 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that the Company will release its third quarter 2022 financial results on Monday, November 14, 2022,…
   Compugen Ltd. (CGEN) is an excellent investment, but the stock is overvalued/undervalued right now  2022/10/24 11:24:00 US Post News
The share price of Compugen Ltd. (NASDAQ:CGEN) fell to $0.83 per share on Friday from $0.87. While Compugen Ltd. has underperformed by -4.87%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CGEN fell by -87.33%, with highs and lows ranging from $7.48 to $0.51, whereas the […]
   Compugen Ltd. (CGEN) Sitting On The Launch Pad, Waiting For Long Term Investors  2022/10/22 14:00:00 Stocks Register
Compugen Ltd. (NASDAQ:CGEN) price on Friday, October 21, fall -4.87% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.83. A look at the stock’s price movement, the close in the last trading session was $0.87, moving within a range at $0.80 and $0.87. The beta value (5-Year … Compugen Ltd. (CGEN) Sitting On The Launch Pad, Waiting For Long Term Investors Read More »
   Compugen Ltd. (NASDAQ: CGEN): Can A Stock Be -79.71% Lower Year-To-Date And Still Be A Loser?  2022/10/21 12:30:00 Marketing Sentinel
Compugen Ltd. (NASDAQ:CGEN)’s traded shares stood at 1.73 million during the last session, with the company’s beta value hitting 2.31. At the close of trading, the stock’s price was $0.87, to imply an increase of 0.97% or $0.01 in intraday trading. The CGEN share’s 52-week high remains $7.48, putting it -759.77% down since that peak … Compugen Ltd. (NASDAQ: CGEN): Can A Stock Be -79.71% Lower Year-To-Date And Still Be A Loser? Read More »
   Earnings Scheduled For May 16, 2022  2022/05/16 09:18:44 Benzinga
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ: ACRX ) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. • Synthetic Biologics (AMEX: SYN ) is likely to report earnings for its first quarter. • Passage Bio (NASDAQ: PASG ) is estimated to report earnings for its first quarter. • Taysha Gene Therapies (NASDAQ: TSHA ) is expected to report earnings for its first quarter. • HOOKIPA Pharma (NASDAQ: HOOK ) is likely to report quarterly loss at $0.24 per share on revenue of $14.53 million. • Sunworks (NASDAQ: SUNW ) is likely to report quarterly loss at $0.26 per share on revenue of $28.70 million. • Data Storage (NASDAQ: DTST ) is estimated to report quarterly earnings at $0.01 per share on revenue of $6.00 million. • 1847 Goedeker (AMEX: GOED ) is projected to report quarterly earnings at $0.04 per share on revenue of $152.35 million. • BIO-key Intl (NASDAQ: BKYI ) is estimated to report quarterly loss at $0.22 per share on revenue of $1.
   Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2021 Results - Earnings Call Transcript  2022/02/24 17:56:08 Seeking Alpha
   Compugen GAAP EPS of -$0.10 beats by $0.04  2022/02/24 12:06:54 Seeking Alpha
Compugen press release (CGEN): Q4 GAAP EPS of -$0.10 beats by $0.04.As of December 31, 2021, cash, cash related accounts, short-term and long-term bank deposits totaled to…
   Compugen Q4 2021 Earnings Preview  2022/02/23 18:57:31 Seeking Alpha
Compugen (NASDAQ:CGEN) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open.The consensus EPS Estimate is -$0.13 (-30.0% Y/Y) and the…
   Compugen to Release Fourth Quarter and Full Year 2021 Results on Thursday, February 24, 2022  2022/02/10 12:00:00 PR Newswire
HOLON, Israel, Feb. 10, 2022 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its fourth quarter and full year 2021 financial results on Thursday, February
   Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2021 Results - Earnings Call Transcript  2022/02/24 17:56:08 Seeking Alpha
   Compugen GAAP EPS of -$0.10 beats by $0.04  2022/02/24 12:06:54 Seeking Alpha
Compugen press release (CGEN): Q4 GAAP EPS of -$0.10 beats by $0.04.As of December 31, 2021, cash, cash related accounts, short-term and long-term bank deposits totaled to…
   Compugen Q4 2021 Earnings Preview  2022/02/23 18:57:31 Seeking Alpha
Compugen (NASDAQ:CGEN) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open.The consensus EPS Estimate is -$0.13 (-30.0% Y/Y) and the…
   Compugen to Release Fourth Quarter and Full Year 2021 Results on Thursday, February 24, 2022  2022/02/10 12:00:00 PR Newswire
HOLON, Israel, Feb. 10, 2022 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its fourth quarter and full year 2021 financial results on Thursday, February
   Compugen to Present at the 11th Annual SVB Leerink Global Healthcare Conference  2022/02/09 12:00:00 PR Newswire
HOLON, Israel, Feb. 9, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that management will present at the 11th Annual SVB Leerink Global Healthcare Conference (virtual), on…

calendar